When was CILcare founded?

CILcare was founded in 2014 and raised its 1st funding round 10 years after it was founded.

Where is CILcare located?

CILcare is headquartered in Montpellier, France.

How many employees does CILcare have?

As of Sep 30, 2026, the latest employee count at CILcare is 69.

Is CILcare a funded company?

CILcare is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Dec 08, 2024.

When was the latest funding round of CILcare?

CILcare's latest funding was a $***** Series A round on Dec 08, 2024, with participation from 6 investors.

Where does CILcare rank among its competitors?

CILcare ranks 4th amongst 864 active competitors, of which 58 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Helogen, which secured $7.1M in Sep, 2026.

Who are the top competitors of CILcare?

CILcare's top competitors include Alloy Therapeutics, Simulations Plus and Manifold Bio. Among them, Helogen secured the most recent funding round in September, 2026.

CILcare - 2026 Company Profile, Team, Funding & Competitors

CILcare is a series A company based in Montpellier (France), founded in 2014 by Sylvie Pucheu and Celia Belline. It operates as a Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus. CILcare has raised $42.3M in funding. The company has 864 active competitors, including 58 funded and 50 that have exited. Its top competitors include companies like Alloy Therapeutics, Simulations Plus and Manifold Bio.

Company Details

CILcare is an R&D services company specialised in the development of drug candidates for hearing disorders (tinnitus, hearing loss) and otic disorders (ENT). The company provides preclinical services for research and development related to the hearing disorders area.

Website: www.cilcare.com/
Social
Email ID: *****@cilcare.com
Phone Number: +33 **********

Key Metrics

Founded Year

2014

Location

Montpellier, France

Stage

Series A

Total Funding

$42.3M in 1 round

Latest Funding Round

Series A, Dec 08, 2024, $*****

Investors

Shionogi & 6 more

Ranked

4^th among 864 active competitors

Employee Count

69 as on Sep 30, 2026

Similar Companies

Alloy Therapeutics & 885 more

View CILcare's full profile

CILcare has raised a total funding of $42.3M over 1 round. Its latest funding round was a Series A round on Dec 08, 2024 for $*****. 6 investors participated in its latest round. CILcare has 7 institutional investors.

Here is the list of recent funding rounds of CILcare:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 08, 2024	9958481	Series A	1042642	6095920	1141717	2620732

Access funding benchmarks and valuations. Sign up today!

View details of CILcare's funding rounds and investors

The founders of CILcare are Sylvie Pucheu and Celia Belline.

Here are the details of CILcare's key team members:

Sylvie Pucheu: Founder of CILcare.
Celia Belline: Founder & CEO of CILcare.

View details of CILcare's Founder profiles and Board Members

CILcare's employee count trend

CILcare has 69 employees as of Sep 26. Here is CILcare's employee count trend over the years:

Uncover CILcare's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CILcare include Alloy Therapeutics, Simulations Plus and Manifold Bio. Here is the list of Top 10 competitors of CILcare, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	69/100
2nd	Simulations Plus 1996, Lancaster (United States), Acquired	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
3rd	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	54/100
4th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, Galia Gestion & 5 others	44/100
5th	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Kima Ventures & 5 others	52/100
6th	Helogen 2024, Mountain View (United States), Seed	Provider of space-based biomanufacturing and drug discovery services	$7.1M	RRE Ventures, Blisce & 3 others	51/100
7th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, Spinnotec & 3 others	51/100
8th	Arctoris 2016, Abingdon (United Kingdom), Seed	Provider of automated wet lab biology research and data generation services	$3.93M	RT, TD Veen & 7 others	51/100
9th	Vipragen 2012, Bengaluru (India), Series A	Provider of drug discovery and development services	$1.9M	Advina Global Health Care, KITVEN & 42 others	50/100
10th	Syenex 2022, Chicago (United States), Series B	Developer of cell-specific delivery systems and programmable cell engineering payloads	$13.7M	KdT Ventures, AlleyCorp	50/100